Current weak economic recovery will likely lead to continued sluggish growth in R&D spending by firms, says a new OECD report
It’s often hard to quantify, but angel investing is a growing around the world. New data indicate this will be key to overcoming the growth challenges facing entrepreneurs, says the OECD's Karen Wilson
The pharma industry spent less on drug R&D last year than at any time in the last three years and there was a fall in the number of drugs getting approval, and of products in early-stage trials
The EU’s new roadmap for low-carbon growth aspires to protect the environment at the same time as spurring the development of new markets and boosting the economy. But can green really equal competitive?
Austerity measures are leading to changes in tuition fees, collaboration with industry, philanthropic funding and funding from donations, says European University Association.